OPERF
NBIX icon

Oregon Public Employees Retirement Fund’s Neurocrine Biosciences NBIX Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Buy
20,784
+200
+1% +$29.7K 0.04% 355
2026
Q1 		$2.71M Buy
20,584
+651
+3% +$86.4K 0.04% 395
2025
Q4 		$2.83M Hold
19,933
– – 0.04% 373
2025
Q3 		$2.8M Sell
19,933
-300
-1% -$40.6K 0.04% 376
2025
Q2 		$2.54M Hold
20,233
– – 0.04% 328
2025
Q1 		$2.24M Sell
20,233
-400
-2% -$50.7K 0.04% 353
2024
Q4 		$2.82M Buy
20,633
+117
+0.6% +$14.5K 0.05% 289
2024
Q3 		$2.36M Sell
20,516
-436
-2% -$59.8K 0.04% 356
2024
Q2 		$2.88M Sell
20,952
-3,643
-15% -$500K 0.06% 271
2024
Q1 		$3.39M Sell
24,595
-3,173
-11% -$433K 0.07% 247
2023
Q4 		$3.66M Buy
27,768
+341
+1% +$39.3K 0.06% 268
2023
Q3 		$3.09M Sell
27,427
-730
-3% -$76.9K 0.04% 401
2023
Q2 		$2.66M Sell
28,157
-13,267
-32% -$1.3M 0.03% 474
2023
Q1 		$4.19M Buy
41,424
+71
+0.2% +$7.39K 0.05% 341
2022
Q4 		$4.94M Buy
41,353
+13,455
+48% +$1.58M 0.06% 307
2022
Q3 		$2.96M Buy
27,898
+553
+2% +$56.1K 0.04% 393
2022
Q2 		$2.67M Sell
27,345
-3,000
-10% -$277K 0.04% 364
2022
Q1 		$2.85M Sell
30,345
-700
-2% -$59.3K 0.03% 551
2021
Q4 		$2.64M Sell
31,045
-793
-2% -$72.9K 0.03% 503
2021
Q3 		$3.05M Sell
31,838
-420
-1% -$39.7K 0.03% 426
2021
Q2 		$3.14M Buy
32,258
+916
+3% +$87.8K 0.04% 432
2021
Q1 		$3.05M Buy
31,342
+30,453
+3,426% +$3.19M 0.04% 416
2020
Q4 		$85K Sell
889
-8,300
-90% -$802K ﹤0.01% 1576
2020
Q3 		$884K Sell
9,189
-600
-6% -$69.4K 0.01% 828
2020
Q2 		$1.19M Buy
+9,789
New +$1.08M 0.02% 695

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Oregon Public Employees Retirement Fund's NBIX Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Neurocrine Biosciences (NBIX) stake by 0.97% in Q2 2026, buying an estimated $29.7K and bringing the position to 20,784 shares worth $3.5M. The position accounts for 0.04% of the portfolio, ranked #355.

Oregon Public Employees Retirement Fund first reported a position in NBIX in Q2 2020 and has held it in 25 quarters since. The position peaked at $4.94M in Q4 2022. 388 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 20,784 shares of Neurocrine Biosciences worth $3.5M as of Q2 2026.
  • Oregon Public Employees Retirement Fund bought 200 Neurocrine Biosciences shares in Q2 2026, an estimated $29.7K.
  • Neurocrine Biosciences made up 0.04% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #355 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Neurocrine Biosciences in Q2 2020 and has held it in 25 quarters since.
  • Oregon Public Employees Retirement Fund's Neurocrine Biosciences position peaked at $4.94M in Q4 2022.
  • 388 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.